1. Home
  2. HNVR vs TTRX Comparison

HNVR vs TTRX Comparison

Compare HNVR & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

HOLD

Current Price

$24.66

Market Cap

153.5M

Sector

Finance

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$10.18

Market Cap

281.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNVR
TTRX
Founded
2008
2015
Country
United States
United States
Employees
N/A
2
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
281.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
HNVR
TTRX
Price
$24.66
$10.18
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$24.50
$8.00
AVG Volume (30 Days)
65.3K
100.3K
Earning Date
04-27-2026
05-31-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
N/A
N/A
Revenue This Year
$35.49
N/A
Revenue Next Year
$8.61
N/A
P/E Ratio
$99.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.91
$2.57
52 Week High
$25.61
$11.69

Technical Indicators

Market Signals
Indicator
HNVR
TTRX
Relative Strength Index (RSI) 59.71 70.79
Support Level $22.09 $3.28
Resistance Level N/A $11.69
Average True Range (ATR) 0.72 1.12
MACD 0.15 0.06
Stochastic Oscillator 70.09 66.13

Price Performance

Historical Comparison
HNVR
TTRX

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: